These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Plasmapheresis in the treatment of severe and malignant arterial hypertension]. Legkonogov AV; Kukharchuk VV; Kutsenko AI; Arabidze GG; Zaruba AIu Sov Med; 1988; (10):38-42. PubMed ID: 3242094 [No Abstract] [Full Text] [Related]
3. [On the evaluation of therapeutic effects in hypertension (described by the example of Guanoxan)]. Siedek H; Klein K; Grübl M Munch Med Wochenschr; 1965 Oct; 107(43):2119-24. PubMed ID: 5899029 [No Abstract] [Full Text] [Related]
4. Clinical evaluation of debrisoquin in the treatment of hypertension. Rosendorff C; Marsden CD; Cranston WI Arch Intern Med; 1968 Dec; 122(6):487-90. PubMed ID: 5721874 [No Abstract] [Full Text] [Related]
5. [Clinical picture and therapy of malignant hypertension]. Schoeppe W; Brecht HM; Koch KM Med Welt; 1975 Mar; 26(10):417-21. PubMed ID: 1123984 [No Abstract] [Full Text] [Related]
6. [The prognosis of arterial hypertension and its modification by antihypertensive therapy]. Holzgreve H Internist (Berl); 1981 Mar; 22(3):156-61. PubMed ID: 7012081 [No Abstract] [Full Text] [Related]
8. [Use of plasmapheresis in the treatment of patients with severe arterial hypertension refractory to drug therapy]. Legkonogov AV; Kutsenko AI; Zaruba AIu; Arabidze GG; Kukharchuk VV Ter Arkh; 1988; 60(6):60-4. PubMed ID: 3206373 [TBL] [Abstract][Full Text] [Related]
9. Malignant hypertension treated with modern antihypertensive drugs. Voudoukis IJ; Caldwell JR Pa Med; 1974 Jul; 77(7):43-8. PubMed ID: 4841134 [No Abstract] [Full Text] [Related]
10. Survival and mortality in malignant (grade IV) and grade 3 hypertension. Trends in consecutive, actively treated groups. Hood B; Orndahl G; Björk S Acta Med Scand; 1970 Apr; 187(4):291-302. PubMed ID: 5447093 [No Abstract] [Full Text] [Related]
11. The prognosis of untreated and of treated hypertension and advantages of early treatment. Smirk FH Am Heart J; 1972 Jun; 83(6):825-40. PubMed ID: 4559696 [No Abstract] [Full Text] [Related]
14. [Role of certain factors in prognosis of the course of malignant hypertension in terminal stage of chronic renal insufficiency and the problems of therapeutic tactics]. Shraer TI; Torgunakov AP; Gorbunov VV; Osipov LE Urol Nefrol (Mosk); 1976; (2):18-22. PubMed ID: 982716 [No Abstract] [Full Text] [Related]
15. [Prognosis of hypertension, improved by drug therapy?]. Moeller J Lebensversicher Med; 1970 Jul; 22(4):79-83. PubMed ID: 4397698 [No Abstract] [Full Text] [Related]
16. [Prognosis in arteriel hypertension under treatment with antihypertensive drugs]. Thygesen K; Harvald B Ugeskr Laeger; 1975 Jan; 137(5):241-5. PubMed ID: 1136030 [No Abstract] [Full Text] [Related]
17. [Clinical studies on differential therapy of hypertension with dichlorophenylaminoimidazoline hydrochloride (Haemiton)]. Seifert A; Hafemeister G; Kirchner D; Wöstenberg D; Tiedcke H; Ullmann W Dtsch Gesundheitsw; 1970 Dec; 25(50):2369-74. PubMed ID: 5509665 [No Abstract] [Full Text] [Related]
18. Guanoxan (compound 1003) in the treatment of hypertension. Ozen MA; Kadiglu A Curr Ther Res Clin Exp; 1965 Sep; 7(9):548-57. PubMed ID: 4953855 [No Abstract] [Full Text] [Related]